NEOADJUVANT THERAPIES

Clinical trials for NEOADJUVANT THERAPIES explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT THERAPIES trials appear

Sign up with your email to follow new studies for NEOADJUVANT THERAPIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

Immunotherapy-Chemo combo aims to make inoperable esophageal cancer removable

Disease control Ongoing

This phase 2 trial tests whether combining the immunotherapy drug cardenilimab with standard chemotherapy can shrink locally advanced esophageal cancer that cannot be surgically removed at first. The goal is to turn these tumors into operable ones, potentially improving survival.…

Matched conditions: NEOADJUVANT THERAPIES

Phase: PHASE2 • Sponsor: Li Zhang • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

NEOADJUVANT THERAPIES

Get alerted when new NEOADJUVANT THERAPIES trials appear

Immunotherapy-Chemo combo aims to make inoperable esophageal cancer removable